These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37804134)

  • 41. Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
    Browne AJ; Chipeta MG; Haines-Woodhouse G; Kumaran EPA; Hamadani BHK; Zaraa S; Henry NJ; Deshpande A; Reiner RC; Day NPJ; Lopez AD; Dunachie S; Moore CE; Stergachis A; Hay SI; Dolecek C
    Lancet Planet Health; 2021 Dec; 5(12):e893-e904. PubMed ID: 34774223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol.
    Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Mohona TM; Rahman A; Abdullah SAHM; Islam MS; Kaydos-Daniels SC; Styczynski AR
    BMC Health Serv Res; 2022 Oct; 22(1):1239. PubMed ID: 36207710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
    Ashley EA; Recht J; Chua A; Dance D; Dhorda M; Thomas NV; Ranganathan N; Turner P; Guerin PJ; White NJ; Day NP
    J Antimicrob Chemother; 2018 Jul; 73(7):1737-1749. PubMed ID: 29514279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis.
    Allel K; Stone J; Undurraga EA; Day L; Moore CE; Lin L; Furuya-Kanamori L; Yakob L
    PLoS Med; 2023 Jun; 20(6):e1004199. PubMed ID: 37347726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Community knowledge and practices regarding antibiotic use in rural Mozambique: where is the starting point for prevention of antibiotic resistance?
    Cambaco O; Alonso Menendez Y; Kinsman J; Sigaúque B; Wertheim H; Do N; Gyapong M; John-Langba J; Sevene E; Munguambe K
    BMC Public Health; 2020 Jul; 20(1):1183. PubMed ID: 32727445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: Lessons from a mixed-methods study in a tertiary care hospital in Ethiopia.
    Gebretekle GB; Haile Mariam D; Abebe W; Amogne W; Tenna A; Fenta TG; Libman M; Yansouni CP; Semret M
    PLoS One; 2018; 13(12):e0208447. PubMed ID: 30571688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption.
    Limmathurotsakul D; Sandoe JAT; Barrett DC; Corley M; Hsu LY; Mendelson M; Collignon P; Laxminarayan R; Peacock SJ; Howard P
    J Antimicrob Chemother; 2019 Aug; 74(8):2122-2127. PubMed ID: 31074489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barriers and pathways to environmental surveillance of antibiotic resistance in middle- and low-income settings: a qualitative exploratory key expert study.
    Peters AC; Larsson DGJ; Laxminarayan R; Munthe C
    Glob Health Action; 2024 Dec; 17(1):2343318. PubMed ID: 38813982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence of factors influencing self-medication with antibiotics in low and middle-income countries: a systematic scoping review.
    Torres NF; Chibi B; Middleton LE; Solomon VP; Mashamba-Thompson TP
    Public Health; 2019 Mar; 168():92-101. PubMed ID: 30716570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic stewardship in perinatal and neonatal care.
    Ramasethu J; Kawakita T
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):278-283. PubMed ID: 28735809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies to improve antibiotic access and a way forward for lower middle-income countries.
    Wasan H; Reeta KH; Gupta YK
    J Antimicrob Chemother; 2024 Jan; 79(1):1-10. PubMed ID: 38008421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries.
    Okeke IN; Lamikanra A; Edelman R
    Emerg Infect Dis; 1999; 5(1):18-27. PubMed ID: 10081668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial Resistance: An Antimicrobial/Diagnostic Stewardship and Infection Prevention Approach.
    Septimus EJ
    Med Clin North Am; 2018 Sep; 102(5):819-829. PubMed ID: 30126573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthcare provider satisfaction with environmental conditions in rural healthcare facilities of 14 low- and middle-income countries.
    Fejfar D; Guo A; Kelly E; Tidwell JB; Ochieng O; Cronk R
    Int J Hyg Environ Health; 2021 Jul; 236():113802. PubMed ID: 34246055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing Globalization and the Movement of Antimicrobial Resistance between Countries.
    Berndtson AE
    Surg Infect (Larchmt); 2020 Sep; 21(7):579-585. PubMed ID: 32434446
    [No Abstract]   [Full Text] [Related]  

  • 57. Schools of public health in low and middle-income countries: an imperative investment for improving the health of populations?
    Rabbani F; Shipton L; White F; Nuwayhid I; London L; Ghaffar A; Ha BT; Tomson G; Rimal R; Islam A; Takian A; Wong S; Zaidi S; Khan K; Karmaliani R; Abbasi IN; Abbas F
    BMC Public Health; 2016 Sep; 16():941. PubMed ID: 27604901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progress in strategies to combat antimicrobial resistance].
    Yin Y; Chen H; Cao L; Tang L; He F
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1346-1360. PubMed ID: 30152220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
    Thomson KM; Dyer C; Liu F; Sands K; Portal E; Carvalho MJ; Barrell M; Boostrom I; Dunachie S; Farzana R; Ferreira A; Frayne F; Hassan B; Jones E; Jones L; Mathias J; Milton R; Rees J; Chan GJ; Bekele D; Mahlet A; Basu S; Nandy RK; Saha B; Iregbu K; Modibbo F; Uwaezuoke S; Zahra R; Shirazi H; Syed NU; Mazarati JB; Rucogoza A; Gaju L; Mehtar S; Bulabula ANH; Whitelaw A; van Hasselt JGC; Walsh TR;
    Lancet Infect Dis; 2021 Dec; 21(12):1677-1688. PubMed ID: 34384533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries.
    Acharya KP; Subedi D
    Front Public Health; 2020; 8():558576. PubMed ID: 33363074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.